Aligos Therapeutics Presents Data on Chronic Hepatitis B and…
SOUTH SAN FRANCISCO, Calif., April 11, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. ALGSa clinical-stage biopharmaceutical company focused on developing novel therapeutics to address unmet